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Abstract
Background: HIV transmission can be decreased substantially by reducing the burden of undiagnosed HIV infection and
expanding early and consistent use of antiretroviral therapy (ART). Treatment as prevention (TasP) has been proposed as
key to ending the HIV epidemic. To activate TasP in high prevalence countries, like South Africa, communities must be
motivated to know their status, engage in care, and remain in care. Community mobilization (CM) has the potential to
significantly increase uptake testing, linkage to and retention in care by addressing the primary social barriers to
engagement with HIV care—including poor understanding of HIV care; fear and stigma associated with infection, clinic
attendance and disclosure; lack of social support; and gender norms that deter men from accessing care.
Methods/design: Using a cluster randomized trial design, we are implementing a 3-year-theory-based CM intervention
and comparing gains in HIV testing, linkage, and retention in care among individuals residing in 8 intervention
communities to that of individuals residing in 7 control communities. Eligible communities include 15 villages within a
health and demographic surveillance site (HDSS) in rural Mpumalanga, South Africa, that were not exposed to previous
CM efforts. CM activities conducted in the 8 intervention villages map onto six mobilization domains that comprise the
key components for community mobilization around HIV prevention. To evaluate the intervention, we will link a clinic-
based electronic clinical tracking system in all area clinics to the HDSS longitudinal census data, thus creating an open,
population-based cohort with over 30,000 18–49-year-old residents. We will estimate the marginal effect of the
intervention on individual outcomes using generalized estimating equations. In addition, we will evaluate CM processes
by conducting baseline and endline surveys among a random sample of 1200 community residents at each time point
to monitor intervention exposure and community level change using validated measures of CM.
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Discussion: Given the known importance of community social factors with regard to uptake of testing and HIV care, and
the lack of rigorously evaluated community-level interventions effective in improving testing uptake, linkage and
retention, the proposed study will yield much needed data to understand the potential of CM to improve the prevention
and care cascade. Further, our work in developing a CM framework and domain measures will permit validation of a CM
conceptual framework and process, which should prove valuable for community programming in Africa.
Trial Registration: NCT02197793 Registered July 21, 2014.
Keywords: Cluster randomized trial, Community mobilization, South Africa, HIV testing, Engagement in care, Retention in
care, Treatment as prevention
Background
In 2014, UNAIDS established targets in hopes of reach-
ing the end of the HIV epidemic by 2030. The targets
dictate that by 2020, 90% of all people living with HIV
should know their HIV status, 90% of all people with
diagnosed HIV infection will receive sustained antiretro-
viral therapy (ART), and 90% of all people receiving
ART will achieve viral suppression [1]. This 90-90-90
framework was largely the result of ground breaking
research demonstrating that HIV transmission can be
decreased substantially by reducing the burden of
undiagnosed HIV infection and expanding early and
consistent use of ART. [2, 3] Treatment as prevention
(TasP), or treating an HIV-positive person with ART to
reduce their HIV viral load and thus reduce the risk of
forward transmission of the virus to a negative partner,
is the key to ending the HIV epidemic [4, 5]. In high
HIV prevalence countries like South Africa (adult na-
tional HIV prevalence estimated at 16.9%) [6, 7], obser-
vational studies have demonstrated that residents of
communities with greater ART coverage have a lower
risk of HIV acquisition [8].
To activate TasP in high prevalence settings and reach
90-90-90 targets, communities must have access to HIV
testing and treatment and also be motivated to know
their status, engage in care if they test HIV positive, and
remain in care, including medication adherence to
ensure viral suppression. Currently uptake of testing,
linkage to care, and treatment falls short of that needed
to significantly decrease new infections, despite wide-
spread availability of HIV testing and care services.
National data from South Africa indicated that in 2012
while 65.0% of the population reported ever testing for
HIV, with approximately 40% having tested in the last
year, only 37.8% of HIV-positive men and 55.0% of HIV-
positive women knew their HIV status [9]. Though
South Africa has the largest ART program in the world,
only an estimated 52% of eligible patients are on treat-
ment [10], and only an estimated 31% of those living
with HIV have initiated treatment [7]. Furthermore,
population-based data from rural areas in the North
West province in 2014 indicate that less than half of
those on ART are virally suppressed [11]. At current
rates of testing and treatment coverage, South Africa will
fall far short of meeting the 90-90-90 goals.
Primary barriers to testing uptake and engaging in
HIV care are related to social and structural factors that
shape clinical care seeking—these include HIV-related
stigma and fear of disclosure, fears around treatment
side effects, male gender norms that discourage men
from engaging in care, and a general lack of community
awareness about the benefits of HIV care and treatment
[12]. HIV-related stigma leads to delays in HIV testing
and treatment as well as poor adherence to clinic visits
and medication [13–16]. Similarly, fear of ART side
effects and misconceptions around the benefits of early
diagnosis, care and treatment can keep people who are
living with HIV/AIDS (PLWHA) out of care [17, 18].
Finally, gender norms are a major social barrier for test-
ing, linkage to care and treatment for men, as traditional
gendered conceptualizations dictate that it is unmascu-
line to seek care, resulting in men accessing health care
services at lower rates than women [19–22]. Men also
access ART at a far lower rate and at more advanced
stages of disease compared to women [23–27].
Tackling social barriers to HIV prevention, testing and
linkage to care, requires building a sustained, community-
wide response [28]. Community mobilization (CM) has
significant potential to improve testing uptake and linkage
to and retention in care by addressing the social barriers
to engagement with HIV care [12, 29, 30]. There is strong
evidence that CM can improve behavioral outcomes, such
as consistent condom use, by addressing discrimination,
creating social cohesion, and extending social participa-
tion and networks for target communities [28, 31–38].
CM has successfully changed inequitable gender norms
through engaging men to question traditional mascu-
linity and support each other to change social inequal-
ities [37, 39–43]. In the large Project Accept trial, CM
markedly improved HIV testing uptake by changing
community norms around HIV testing through en-
hanced community participation, raising community
awareness, and partnership building [44, 45]. UNAIDS has
designated CM as a critical enabler—or an activity that is
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necessary to support the effectiveness of programs. [46]
Despite this, CM strategies for linkage to and retention in
HIV care have not been rigorously defined or evaluated,
with few conceptual frameworks that provide a theoretical
basis for program design. In fact, few interventions have
improved linkage to and retention in HIV care in resource
poor settings, despite the urgent need [47–49].
To address this gap in interventions to improve link-
age to and retention in HIV care on a community level,
we designed a cluster randomized trial to implement
and evaluate a theory-based CM intervention conducted
and allocated at the community level that addresses
known social barriers to engagement in HIV care. We
aim to determine whether the intervention decreases
undiagnosed infections and improves linkage to and re-
tention in HIV care among adults aged 18–49 years in
the intervention communities as compared to adults
18–49 in the control communities, with the overall goal
of reducing new HIV infections and improving health
outcomes of those living with HIV. We also aim to under-
stand the mechanisms of action of this mobilizing program
through our community surveys and determine what com-
prises the ideal format for delivery of the program. This
manuscript describes the trial protocol.
Methods/design
Study site and population
This study is being conducted in the Agincourt sub-
district of Bushbuckridge in rural Mpumalanga prov-
ince of South Africa—the area is covered by a health
and socio-demographic surveillance system (Agincourt
HDSS) established in 1992 and run by the Medical Re-
search Council/Wits University Rural Public Health
and Health Transitions Research Unit (Agincourt).
Through the annual household and vital events update,
the unit maintains a detailed database and sampling
frame, including geo-coding, of over 20,000 households
and over 115,000 resident individuals living in 31 fully
enumerated villages, 15 of which are participating in
this study [50]. The current study focuses on HDSS res-
idents aged 18–49 years.
Population-based HIV prevalence among the adult
population 15 years and above in the Agincourt HDSS
was 19.4% in 2010–2011 and peaked at over 45%
among 35–39-year olds [51]. HIV testing and clinical
care for HDSS residents is provided by nine public
health facilities and one public-private-partnership
community health center located within the study area.
These ten facilities serve multiple communities through-
out the HDSS. As community members commonly re-
ceive services outside their village, the study includes
monitoring HIV services provision at all ten health facil-
ities (Fig. 1).
Specific aims
The CM intervention is being evaluated by comparing
uptake of testing, linkage, and retention in care in 15
communities randomized to either an intervention con-
dition (n = 8) or a control condition (n = 7) located
within the Agincourt HDSS. To measure outcomes in
each village, we are linking the longitudinal population-
based HDSS data to a health facility-based electronic
clinical tracking system used in all HDSS health facil-
ities. The linkage of the health facility and census data
allows us to establish an open cohort of approximately
34,000 18–49-year-old residents that includes exposure
data (village of residence) as well as outcome data (HIV-re-
lated clinical care). Using these data, we will evaluate the
effects of the CM intervention by village randomization
arm as well as characterize the HIV care cascade in a high
prevalence population. We will also evaluate the concep-
tual model, including the hypothesized CM processes [52],
through community surveys to monitor intervention
exposure and community level change using validated CM
measures [53]. The specific aims of the study include:
Aim 1, testing
To determine whether uptake of HIV testing among
residents of communities receiving a community mo-
bilizing intervention is higher than residents of
control communities.
Aim 2, linkage
To determine whether linkage to care is higher among
residents of intervention versus control communities as
measured by (a) proportion of those testing HIV positive
who complete CD4 staging within 3 months of diagnosis
and (b) the proportion of those eligible for treatment
who initiate ART within 3 months of CD4 staging.
Aim 3, retention
To determine whether retention in care is higher among
people in intervention compared to control communi-
ties, including (a) proportion of ART initiated patients
not defaulting from care (with no more than a 90-day
gap in treatment during 12 months) and b) those ineli-
gible for ART returning for CD4 staging at 6-month
intervals.
Aim 4, mechanisms
To explore changes in community mobilization do-
mains as well as how differences in each domain associ-
ate with changes in study outcomes (testing, linkage,
and retention) over time.
Community randomization
Communities involved previously in community mobil-
izing activities (n = 12), those not yet fully enumerated in
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2014 (n = 3), and with fewer than 500 permanent resi-
dents (n = 1) were not eligible to participate, leaving 15
communities to randomize. In order to achieve a balance
among villages on the key covariates at baseline, a
restricted or balanced randomization approach [54] was
used, taking into account population size, distance to clos-
est health facility, average levels of SES based on house-
hold assets [55], temporary migration, female-headed
households, and baseline community mobilization scores
[53], collected as part of a survey in 2014. Cluster alloca-
tion cannot be concealed as CM events and activities are
held in public spaces. Further, village leaders were con-
sulted about the trial, consented for their villages to
participate, and were present for the allocation. A
randomization event was carried out with community rep-
resentatives. A biostatistician unfamiliar with the area and
the villages generated 50 different grouped combinations
of intervention and control villages, and these combina-
tions were printed on strips. The assignment was revealed
by asking a community volunteer to pick the winning
randomization scheme out of a bucket containing all 50
possibilities. The program was then launched in the
presence of local leaders and community members.
Intervention design
Overall, our mobilization model adheres to the theory
that social barriers necessitate social change solu-
tions—those which move beyond merely providing ser-
vices or empowering individuals to use services and that
instead construct a collective response out of a group of
individuals [28]. As a result, our intervention addresses
social barriers to testing, and linkage to and retention in
HIV care, specifically, poor awareness or understanding
of HIV care; fear and stigma associated with HIV infec-
tion, clinic attendance, and disclosure; lack of social sup-
port; and gender norms, particularly those that deter
men from accessing care. These content areas are
addressed by implementing activities across the inter-
vention villages that engage communities in social chan-
ge—specifically activities that map onto six CM domains
distilled from the social sciences literature and validated
in the study area (see Fig. 2) [52]. The six domains of
Fig. 1 Map of the Agincourt Health and Socio-Demographic Surveillance System (Agincourt HDSS) and surrounding area
Lippman et al. Implementation Science  (2017) 12:9 Page 4 of 13
mobilization that are being addressed for CM to suc-
cessfully impact HIV prevention are (1) a shared issue or
concern that is the target of change, (2) community
sensitization or building of critical consciousness, (3) an
organizational structure with links to groups/networks,
(4) leadership (individual and/or institutional), (5) col-
lective activities/actions, and (6) community cohesion.
These domains represent community factors integral to
social change that must be addressed or modified for
mobilization to occur and to impact behaviors, social
norms, and health outcomes in the communities.
The program is being carried out in partnership with
Sonke Gender Justice, a South African non-governmental
organization (NGO) dedicated to activism and health pro-
gramming at the intersection of HIV and gender equity.
Intervention activities and workshop content have been
adapted from material that has been compiled, pilot
tested, and successfully utilized in our previous collabora-
tive work on community mobilization to address gender
norms [56]. In preparation for the intervention we both
refined previously designed activities to fit the new pro-
grammatic content and further developed new activities
addressing social barriers to testing, linkage to, and reten-
tion in care. New activities, workshop content, print mate-
rials, and short films were developed to specifically
address the issue of treatment as prevention (TasP) and
HIV treatment literacy. We also added more in depth con-
tent on stigma and social norms surrounding HIV and
health care utilization. Over 16 community-based activ-
ities have been developed, standardized and manualized
into a toolkit of community mobilizing activities; 50 mod-
ules covering 7 themes have been included in a workshop
manual; and a handbook for creation of community
mobilizing teams has been developed and refined [57].
The mobilizing team named the intervention “Tsima ra
rihanyu,” which means “working together to plow the
fields for health” in the local language.
Tsima ra rihanyu is being implemented over 3 years by
a team of 16 community mobilizers with two interven-
tion coordinators, a logistician, and a member of the
senior staff at Sonke Gender Justice. Mobilizers were
selected from intervention communities and assigned to
work in their own villages whenever possible. These in-
dividuals underwent extensive training from master
trainers at Sonke on all intervention activities and are
supervised by the intervention coordinators. As part of
the Tsima ra rihanyu activities, the mobilizers also iden-
tified and trained community action teams (CATs) in
each village. CATs are volunteers from the community
who engage with the CM activities and lead mobilization
efforts in their community; mobilizers work closely with
CATs as they implement activities. This CAT model has
been successfully utilized by Sonke in previous efforts.
Intervention activities aim to open dialogue and com-
munity discussion about testing, linkage to and retention
in care through CM activities, harnessing networks for
message dissemination, and forging organized commu-
nity action through establishing CATs, engaging leader-
ship, and fostering community cohesion to support
people living with HIV (see Table 1). The CM team,
along with the CATs, are carrying out activities to gener-
ate a shared concern and raise consciousness around
engagement in HIV prevention and care, with a focus on
the importance of testing, linkage to and retention in
care for individuals, and overall community health.
Activities to raise consciousness include intensive small
group workshops, community outreach, including the-
ater, debates and discussions, and digital story work-
shops—an event where real stories of individuals’
experiences with testing and engagement in care are told
Fig. 2 Conceptual framework of the intervention, community mobilization components, and study goals
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and then screened to generate discussion, and engage-
ment with clinic staff. We launched the intervention
with smaller group activities and workshops that focus
on raising community consciousness and generating a
shared concern around testing, linkage to care and treat-
ment, and identifying CAT membership in order to set
the stage for implementation of the full complement of
CM activities. CATs act as community/clinic liaisons
and work with the CM team to engage local leadership
and stakeholders in these discussions and also work with
existing organizations and networks, such as support
groups or home-based care groups, as part of efforts to
build community consciousness and shared concerns
around TasP. As a next step, the CATs and mobilizers
work to lead collective actions around testing, linkage,
and retention such as designing community murals,
hosting soccer tournaments, and other appropriate com-
munity events. In these events, efforts to build social
cohesion and engage leadership are emphasized. Illustra-
tive activities are included in Table 1.
Intervention monitoring
Intervention activities are continuously monitored in
order to quantify intervention consistency (fidelity) as
well as dosage and reach by village. Data collection
forms are completed by mobilizers and CAT members
Table 1 Intervention activities addressing social barriers to treatment as prevention, mapped onto community mobilization domains
Social barriers to TasP
CM domains Stigma related to testing,
care, and treatment
Increased knowledge
(diminish fears) about
testing and treatment
Gender norms around testing
and treatment
Social support around testing
and treatment
Building shared
concerns and
community
consciousness
*2-Day intensive and single
session workshops
-focus on community
stigma around testing/
treatment
*Door to door outreach
*Digital stories and film
screening
*Engaging with clinic staff
*Street theater-focused on
barriers to testing/treatment
*Digital stories and films on
testing and care experiences
*Door to door outreach
*Educational events
*2-Day and intensive and single
session workshops on gender
norms and the benefits/barriers
to men engaging in testing and
care
*Street theater addressing
gender norms
*2-Day intensive and single
session group workshops-
focused on community barriers
to testing and treatment
*Door to door outreach
*Digital stories screening
Engaging leadership
and stakeholders
(includes traditional
leaders, religious
leaders, clinic leaders,
other community
stakeholders)
*Engaging leaders around
importance of TasP and
barriers in community
*Intensive workshops with
leaders on HIV stigma,
testing/treatment
*Pursuing leadership
commitments to achieving
village testing and
treatment targets (goal
setting)
*Engaging leaders around
importance of TasP and
barriers in community
*Monthly 1-day small
group workshops focused
on benefits of testing and
treatment in community
*Engaging leaders around the
importance of men engaging in
health care
*Seek support from leadership
to enter places of work, taverns,
places where men congregate
*Identifying home based care
support groups in CAT
development
*Engaging leaders in creating
support networks for testing
and treatment as a
community benefit
*Goal setting with leadership
Orgs/networks
(includes NGOs, CBOs,
CATs, other family or
community groups/
networks)
*Working with the key
groups to openly support
and include testing and
treatment in their work in
the communities
*Working with key groups to
understand how testing and
care can improve
community well-being
*Message dissemination
through networks.
*Working with the key groups
(employers, small businesses,
sport teams, etc..) to support
engagement of men in testing/
care
*Dialogues with church leaders
addressing support for male
testing/care
*Identifying home-based care
groups and PLWH in CAT
development *Partnering
with support and treatment
networks
*Founding community
support groups
Collective action *Murals that address stigma
related to testing and
treatment
*Events to support testing
campaigns/treatment access
*Encouraging Tsima
members and affiliates to
HIV test together
*Soccer tournaments that
highlight importance of
testing and treatment
*Events to support testing
campaigns/treatment access
*Home education (open
house) events for networks/
groups
*Community events/forums that
address gender norms and
accessing HIV care *Murals that
address gender norms and HIV
care
*Community events
conducted by CATS, PLWH,
and home-based care groups
to increase community
support around TaSP
*Encouraging Tsima members
and affiliates to HIV test
together
Social cohesion *Visible community support
(events/forums) to reduce
stigma–working with PLWH
*Community events to
dialogue around how
stigma affects the
community and how
communities can respond
*Identifying home based
care groups and PLWH in
CAT development–providing
safe space for discussion
and support
*Events to support stronger
care and treatment networks
*Dialogues with men’s groups
or associations–addressing male
support for testing/care.
*Building CATs with men,
including men LWH
*Work with home-based care
and CATS to establish PLWH
support networks
*Extend networks and
activities to families
*Join CATs, local leaders, and
clinic staff in testing and
treatment strategies.
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in order to capture which activities are undertaken in
the communities and how many residents were in at-
tendance. Monitoring reports are generated monthly
and quarterly to assess the estimated proportion of resi-
dents exposed to the CM intervention in each village
and to ensure the team is reaching intervention coverage
targets. With this system capturing data in real time, any
indication that a village may fall below a given threshold
(i.e., reach 25% of the village population with workshops
annually) can be noted early and corrective action taken
to ensure the village receives additional support from
the mobilizing team. In our past experience implement-
ing CM, this system has allowed us to ensure that all
activity targets are met within the specified timelines.
Data collection
Continuous data collection of HIV-testing and care
delivery visits is underway at all ten health facilities in
the study area by a team of trained data capturers
stationed at the facilities, who both obtain written in-
formed consent from patients to capture clinical visit
data and conduct the HDSS-health facility data linkage
in real time (Fig. 3). The data linkage is done using de-
terministic and probabilistic approaches. After obtaining
written informed consent from a new patient, the data
entry clerk collects a set of identifiers that are used to
search the Agincourt HDSS data. Linkage is attempted
using national ID number and, if a match is not found,
then a second attempt is performed using a combination
of mobile phone number, first name, and date of birth. If
a match is still not found, a search is done using an algo-
rithm based on the Fellegi-Sunter probabilistic record
linkage model [58]. The key identifiers include name,
surname, age or date of birth, sex, village of residence,
and name of another person living in the household
[59]. When potential matches are found, they are
reviewed in the presence of the patient to confirm his or
her identity. In addition to identification of the patient
in the population database, the data entry clerk extracts
clinical information from the patient’s file and logs all
follow-up visits, entering clinical information directly
into a laptop hosting the linkage system. The linkage
system encrypts all data as soon as it is entered; identify-
ing information (e.g., name and phone numbers) are
excluded from analytic datasets.
To measure coverage of the intervention and changes
in the CM domains and other key variables in each com-
munity over time, a cross-sectional, population-based
survey was administered prior to the intervention and a
second survey will take place following the intervention
(Fig. 3). The surveys aim to capture 1200 randomly sam-
pled adults, aged 18–49 years, from the HDSS popula-
tion with approximately 75 people sampled in each of
the 15 study villages at both time points. Eligibility cri-
teria for participation in community surveys include
residence in the home (spending a majority of nights at
home), being 18–49 years of age, and having lived in the
study area for at least 9 of the past 12 months. Surveys
are interviewer-administered in the participant’s home
using computer assisted personal interview (CAPI). Only
one individual per household can be selected. Fieldwor-
kers visit the selected homes to confirm eligibility and
explain the study. Written informed consent is obtained
from all participants prior to the survey; both consent
and the survey are offered in the local language,
Shangaan, or English. All procedures were approved
by the Institutional Review Boards at the University
of North Carolina-Chapel Hill and the University of
California-San Francisco, the Human Research Ethics Com-
mittee (Medical) at the University of the Witwatersrand in
South Africa, and the Mpumalanga Department of Health
and Social Development Research Committee.
Study measures
Primary exposure
Residence in an intervention or control community is
the primary predictor variable for all analyses. Commu-
nity of residence will be determined using the HDSS
data. Household and vital events data are updated annu-
ally and include births, in- and out-migrations and
deaths. Although few individuals are expected to move
within the study area over the course of the study, for
those who do move, exposure will be determined dynamic-
ally over the course of the study such that individuals will
be considered exposed if they were resident in an interven-
tion community in the time period immediately prior to
the outcome. Table 2 summarizes the quantitative data
elements that include exposures, outcomes, mediators, and
social and demographic co-variates.
Primary outcomes
For each aim, the primary source of data for outcomes is
the electronic health facility data linked to the HDSS.
An electronic record will be created for every resident of
the 15 study villages captured in the population data-
base; with this approach, we will treat the entire eligible
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(18–49-year old) population in the area as an open
cohort, assuming no clinic visits were made if none were
captured for a given individual. Study outcomes include
HIV testing uptake in the past 12 months among resi-
dents of negative or unknown status (aim 1); linkage to
HIV care, or having returned to the clinic following
diagnosis for ART initiation or follow-up care (aim 2);
and retention in care, defined as remaining on ART with
no more than a 90-day gap in coverage over a 12-month
period (aim 3).
Mediators: community mobilization
Quantitative measures of CM will be collected in the
two community surveys; CM is comprised of six hypoth-
esized domains, outlined in Table 1. Questions regarding
a shared concern about HIV/AIDS are designed to cap-
ture whether members of the community define HIV
testing and care as important, problematic, and mutable
issues, and whether they believe they can work together
to address HIV. The scale for critical consciousness is
designed to capture whether members of the community
are undergoing processes of critical reflection and dia-
logue about their circumstances and ways to improve
their lot. Questions about leadership capture leadership
capacity, diversity, responsiveness, accessibility, and sup-
port of collective decision making. Questions regarding
organizations and networks are designed to capture the
existence and influence of community-based organiza-
tions, groups, and networks that can serve as a resource
in mobilizing—both for exchange and diffusion of ideas
Table 2 Summary of quantitative data elements
Domain Instrument/measure Data source and frequency
Primary exposure
Village Village of residence (binary; intervention vs. control village) HDSS-annual
Primary outcomes
Testing uptake (aim 1) Binary: tested/untested past 12 months, among HIV-negative
or unknown status residents
Electronic health facility records-ongoing
Binary: known HIV status–either confirmed positive or tested
within the last 12 months
Electronic health facility records-ongoing
Linkage to HIV care (aim 2) Binary: received baseline CD4 results and evidence of follow-up
care (additional CD4, viral load, or treatment initiation) within
3 months of testing HIV positive
Electronic health facility records-ongoing
Binary: treatment initiation within 3 months of positive diagnosis
among those eligible for ART
Electronic health facility records-ongoing
Retention in HIV care (aim 3) Binary: HIV patients on or initiating ART who have no more than
a 90-day gap in medication received in the 12-month period
(no defaulting).
Electronic health facility records-ongoing
Binary: HIV patients not ART eligiblea who have a repeat CD4
test 6–12
months after initial CD4
Electronic health facility records-ongoing
Meditator/mechanism
Community mobilization Six domains of community mobilization measure [53] Population-based surveys (years 1 and 5)
Covariates
Demographics Age, SES, gender, migration status HDSS-annual
Social norms Stigma [81]; gender norms [41]; community support for HIV
testing and treatment [53]
Population-based surveys (years 1 and 5)
Secondary outcomes
Testing (aim 1) Median CD4 of people initiating ART (to explore earlier testing,
entry into care)
Electronic health facility records-ongoing
Re-engagement in care (aims 2 and 3) Patients out of care (not retained) who are re-engaged in care
(have a CD4 test/initiate or re-initiate treatment).
Electronic health facility records-ongoing
Viral suppression Proportion of residents with viral load <400 copies/ml Electronic health facility records-ongoing
Secondary exposure
Intervention coverage Reported exposure to intervention events Population-based surveys (years 1 and 5)
aPrior to September 2016, patients were considered ART eligible with one or more of the following criteria: pregnancy, CD4 count lower than 500 cells/mm [3],
active tuberculosis, WHO stage 3 or 4, or initiation of ART per clinician discretion. Universal treatment was planned to be instituted in September 2016; therefore,
all HIV-positive individuals will be considered treatment eligible after this date; the pre-ART definition will only apply to the period prior to implementation of the
universal treatment guidelines
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and as a structure that can be utilized for community or-
ganizing. Questions regarding collective action are designed
to capture the presence, breadth, and quantity of collective
activities in the villages aimed at social change. Finally,
questions about social cohesion capture the level of work-
ing trust in a community. Scales performed extremely well
for all six CM domains in our 2012 survey [53].
Analysis
One-way frequency tables for all variables and measures
of central tendency and variability for continuous vari-
ables will be generated to perform range checks, quan-
tify the amount of missing data, and yield valuable
descriptive findings that will further characterize the
care cascade in the study population. These analyses will
also be stratified by randomization group (i.e., interven-
tion versus control) using cluster-based two-group com-
parison methods (e.g., Rao-Scott chi-square) to check
the equality of intervention and control group covariates
at baseline. If the intervention and control groups are
found to differ significantly at baseline on one or more
covariates (e.g., gender; mean age of village residents),
we will use methods based on the Rubin causal model
(e.g., propensity scores, targeted maximum likelihood
estimation, double-robust estimation) [60] to obtain the
desired marginal effect estimates under the counterfac-
tual assumption of balanced groups [61–65]. We will
assess and document the amount of missing data from
health facility systems and community surveys. In the
unlikely event that a variable has >5% of missing data,
we will address incomplete data via either inverse prob-
ability of censoring weights (IPCW) or use multiple
imputation (MI) [66], as it makes the relatively mild as-
sumption that incomplete data arise from a conditionally
random (MAR) mechanism rather than the completely
random process (MCAR) assumed by ad hoc methods
such as list-wise data deletion [67]. For MI, auxiliary
variables will inform multiple imputations to increase
the likelihood of meeting the MAR assumption [68, 69].
We hypothesize that following the intervention, for
the intervention community relative to the control
community residents:
1. The odds of HIV testing will be higher (specific aim 1);
2. The odds of linkage to care will be higher (among
those HIV-infected; specific aim 2);
3. The odds of retention in care will be higher (among
those HIV-infected; specific aim 3); and
4. The community means of the six domains of
community mobilization will be higher and associated
with individual level outcomes (specific aim 4).
Primary analyses will follow an intent-to-treat (ITT)
approach and will be unadjusted except for intervention
group, and, for longitudinal analyses, time, and the
group-by-time interaction. Individual will be the unit of
analysis. Our principal interest is to estimate the mar-
ginal or population-average effect of the intervention on
each outcome rather than the effect for a hypothetical
average subject [70]. Moreover, within-subject correla-
tions among outcomes are considered nuisance parame-
ters rather than quantities of interest to be modeled
explicitly. Accordingly, generalized estimating equations
(GEE) will be used to perform the proposed primary lon-
gitudinal analyses, including planned time-averaged
comparisons of post-baseline measurements across the
intervention and control arms to test primary hypoth-
eses 1–3 listed above. Alpha will be set at .05 for these
planned comparisons of each separate outcome. Any
additional post-hoc comparisons (e.g., paired compari-
sons of the control and intervention arms at each time
point) will maintain a nominal alpha level of .05 through
the use of simulation-based stepdown multiple compari-
son methods [71]. GEE accounts for correlation of
repeated measurements from the same research partici-
pant via computation of a working correlation matrix
and yields the desired marginal population-average effect
estimates [72]. Village ID will be included as a nested
fixed effect or via alternating logistic regression (ALR) to
account for clustering of persons nested within villages.
GEE estimates are consistent even if the correlation
structure is mis-specified, though GEE’s statistical effi-
ciency improves as the working correlation structure
more closely approximates the actual correlation structure
[73]. Thus, several suitable working correlation structures
will be considered (e.g., unstructured, AR(1), exchange-
able) [74]. The QIC or a similar statistic will be used to
select the final working correlation structure [75]. Robust
Huber-White “sandwich” standard errors will be used to
obtain correct inferences even if the chosen correlation
structure remains slightly mis-specified.
For hypothesis 4, cross-sectional population data will be
collected through representative community surveys.
Summary measures of the CM domains before and after
the intervention for each village will be calculated from
this population representative sample. GEE will be used to
model the effects of the pre-post differences in village-
level CM domains on individual residents’ HIV testing,
and, for HIV-positive individuals, linkage and retention to
care using the same overall modeling approach as outlined
above. To examine the relative importance of each of the
six CM domains, initial models will include the pre-post
change scores for each of the six domains in a single
model. Subsequent analyses will isolate the marginal
effects of each domain via G-computation or other
substitution-based estimation strategy [60, 76].
Secondary analyses will extend GEE models to incorpor-
ate additional covariates of interest drawn from the HDSS
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data (e.g., age; gender) and examine their interactions with
intervention assignment to ascertain statistical moder-
ation. Secondary analyses will also evaluate whether
the pre-intervention/post-intervention village-level dif-
ference in the six community mobilization measures
mediate the relationships between intervention village
residence and the primary outcomes. Statistical medi-
ation will be assessed using the causal inference-based
approach of Valeri and VanderWeele, which yields
optimal estimates of indirect effects in the presence of
binary outcomes and moderator-mediator interactions
[77]. Mplus will be used to implement these mediation
analyses because it allows for causal mediation assess-
ment incorporating robust standard errors to address
clustering of individuals within villages [78]. Significant
indirect and total effects of the intervention on testing,
linkage, and retention accompanied by non-significant
direct effects will signify mediation in this context.
Power
Minimum detectable differences were calculated ac-
cording to the methods for proportions in cluster ran-
domized trials proposed by Hayes and Moulton [54],
yielding conservative effect size estimates based on
clustering by villages. Based on the HDSS data, there
are approximately 30,000 adults 18–49 in the study
area. We assumed an HIV prevalence of 33% in the
adult target population (18–49-year old) [51]. If we
conservatively estimate that testing is constant at 35%
of the population, at least a third of those tested each
year were not tested previously in the study period,
and that test positivity is 15% (again a conservative
estimate), 449 cases of HIV would be newly identified
each year. We further assumed that approximately
50% of individuals who present for CD4 staging would
be eligible for HIV treatment under 2014 guidelines.
Approximately 6000 individuals were known to be on
treatment at clinics in this area in 2014. Our survey
data from 2012 suggests that HIV testing in this
region exhibits an intra-class correlation of 0.014. In
adjustments of power calculations for clustering of
outcomes by village, we conservatively assumed an
intra-class correlation of 0.05. Table 3 includes out-
come estimates for the control proportions based on
current literature [18, 26, 27, 68, 79], and the target
(intervention) proportions with the minimum increase
in proportions that would be detectable as a statisti-
cally significant change at alpha of 0.05 and power of
0.80, given the above assumptions. In 2016 (1 year into
data collection), the South African government
announced universal HIV treatment. This should in-
crease our sample size to assess initiating ART (aim 2)
and retention in care (aim 3) in the second and third
years of the study.
Discussion
The Tsima ra rihanyu program is built on a theory-based
CM model that aims to remove the major social barriers
to successful participation in the HIV care cascade and
ultimately activate the promise of TasP. The cluster-
randomized research design and the linked data sources
including a measure of CM administered through com-
munity surveys will provide a robust structure within
which to evaluate the intervention and simultaneously,
provide insight as to the mechanisms of action in im-
proving testing, linkage, and retention. In addition,
because the study is embedded in an HDSS, we will have
true denominators for our estimates and will therefore
generate much needed population-based data contribut-
ing to improved characterization of the HIV care cas-
cade. These data will also provide an opportunity to
optimize program design through targeting groups with
the greatest need of care support.
This study focuses on community approaches to im-
proving uptake of HIV testing and care and is not focused
on directly mitigating health facility-level barriers to care,
including quality of HIV care, drug stock-outs, long wait
times, or lack of confidentiality. However, the intervention
design does not prohibit mobilization teams and/or CATs
to plan activities at the clinics or with the clinics and does
encourage partnerships with clinic leadership as primary
stakeholders in improving the care cascade. Because inter-
vention and control populations will be accessing the
same group of clinics and because varied quality of care
across the health facilities and different levels of involve-
ment in the intervention by health facility could affect the
study outcomes, the team agreed that any intervention
activities that target health facility leadership or address
health facility services will be conducted in all study health
facilities, in order to ensure that potential effects of clinic-
Table 3 Power calculations–minimum detectable effects
Outcomes: proportion of population Current estimate Intervention group
target
Minimum detectable
difference (proportion)
Testing; tested in past 12 months 35% 60% 19%
Linkage; undergoing CD4 staging within 3 months of positive test 65% 85% 18%
Linkage; eligible for ART who initiate treatment within 3 months 60% 80% 19%
Retention; HIV positive who remain in care at 12 months 50% 70% 19%
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based activities will be consistent across all villages. Add-
itionally, to address basic health facility functionality, and
mitigate any health facility-specific influence on study out-
comes, the team has partnered with the local PEPFAR
partner, Right to Care, to work with all study area health
facilities to ensure that best practices for HIV prevention,
testing, care, and treatment are in place and that monitor-
ing systems and data capture are standardized and that
supplies, including test kits and drugs, are available.
The Tsima ra rihanyu program is also rooted in com-
munity collaboration and feedback, with community
participation in setting goals as well as monitoring pro-
gress towards reaching those goals. A key strength of
this intervention is the ability to assess the care cascade
in each community over time. In the first year of the
intervention, we held goal-setting workshops with each
intervention community to establish commitment and
partnership towards improving HIV outcomes in the
community. The concept of the UNAIDS 90-90-90 goals
was introduced during these meetings and community
leaders, and participants were able to both assess the
current state of HIV testing and care outcomes in their
community and establish annual community goals. Every
6 months, the team will hold a similar community meet-
ing to monitor achievements towards reaching the goals
and renew commitment and partnerships. Clinics are
also receiving feedback on a regular basis, with a team
discussion regarding where attrition is occurring in
order for clinics to focus their efforts in improving
clinical outcomes for their clients.
The study does have some limitations. The Tsima ra
rihanyu program excludes use of mass media or large-
scale public advocacy in order to minimize contamin-
ation in the context of an RCT. This omission will
likely detract from the reach and impact of the inter-
vention. Additionally, given substantial migration in the
area, it is likely that some residents will be classified as
lost to follow-up or out of care when they may have
moved out of the area and remained in care. While
information regarding changes in residency status
(migration) and deaths are updated annually in the
census and will be noted in the data, some residents
captured in the electronic health facility data system
may not present for return visits with no recorded
reason for loss to follow-up. To remedy this, among
those classified as lost, we will select a random sample
of 10% to contact in order to determine their outcome,
including whether they are seeking care elsewhere. This
data will allow us to perform sensitivity analyses [80].
Additionally, we do not have current data on HIV
status of all individuals in the community; therefore,
the true number of residents living with HIV is
unknown. We can, however, estimate the number based
on previous population-based surveys in the area.
Conclusions
This will be one of the first studies to measure the
impact of community mobilization on uptake of testing,
linkage, and retention in care and to identify the mecha-
nisms through which CM impacts engagement in care.
Results can inform community-based initiatives in areas
of high prevalence where uptake of TasP is most critical.
Trial status
The first cross-sectional survey was conducted between
August-November, 2014. Data collection at health facil-
ities in the study catchment area was rolled out across
nine clinics between June and August 2015 and in an
additional clinic from July 2016; clinic data capture is
scheduled to continue in all clinics through 2018. Inter-
vention activities commenced on 1st August 2015; the
intervention is currently entering the second year of a 3-
year intervention, scheduled to close out in July 2018.
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